Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (7535)	4/30/1998 1:53:00 AM
From: scaram(o)uche	Respond to of 9262

[ ICOS ] >> You won't believe it. Pfizer has gone up $16.50 per share since the Viagra announcement on 3/27. At 1.258 billion shares, the "Viagra Market cap" is about $21 billion << Yeah, and, lots of the increase in market cap previous to 3/27 was also due to Viagra. In January at H&Q, Rathman said that the molecule had been extensively tested for safety in phase I testing and that efficacy had been demo'd in a preclinical model. Phase II initiated in 40 patients and as of January, results from about 10 or 15, "certainly not disappointed by what we've seen so far". (I'm working from a tape of the H&Q presentation) Rick